Amyloidosis
A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
A group of diseases in which protein builds up in certain organs localized amyloidosis) or throughout the body systemic amyloidosis). Amyloidosis may be either primary with no known cause), secondary caused by another disease, including some types of cancer, such as multiple myeloma), or hereditary passed down from parents to children). Many organs are affected by amyloidosis. The organs affected may depend on whether the amyloidosis is the primary, secondary, or hereditary form.
A group of diseases in which protein is deposited in specific organs localized amyloidosis) or throughout the body systemic amyloidosis). Amyloidosis may be either primary plasma cell neoplasm) or secondary caused by a long standing infection or another disease or some types of cancer). Generally, primary amyloidosis affects the nerves, skin, tongue, joints, heart, and liver; secondary amyloidosis often affects the spleen, kidneys, liver, and adrenal glands.
A group of diseases in which protein is deposited in specific organs or throughout the body.
A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of amyloid. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
Amyloidosis occurs when abnormal proteins build up and form deposits. The deposits can collect in organs such as the kidney and heart. This can cause the organs to become stiff and unable to work the way they should. There are three main types of amyloidosis:
Any disease manifested by the pathogenic accumulation of amyloid in organs and tissues.
E85.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM E85.9 became effective on October 1, 2022.
This is the American ICD-10-CM version of E85.9 – other international versions of ICD-10 E85.9 may differ.